Skip to main content
. 2022 Aug 16;4(4):fcac206. doi: 10.1093/braincomms/fcac206

Figure 1.

Figure 1

Kaplan–Meier curves for the incidence of cognitive deficits within the first 6 months after a diagnosis of COVID-19. Comparison is made between patients on phenytoin and those on (A) levetiracetam and (B) valproate. Shaded areas represent 95% confidence intervals.